Search Results - "Sengeloev, H"

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT by Domingo-Domènech, E., Boumendil, A., Climent, F., Sengeloev, H., Wahlin, B., Wattad, W., Arat, M., Finel, H., Schapp, N., Ganser, A., Yeshurun, M., Pavone, V., Snowden, J., Finke, J., Montoto, S., Sureda, A., Dreger, P.

“…Systemic anaplastic large cell lymphoma (sALCL) is a rare histological entity expressing the CD30 antigen that comprises around 11% of peripheral T-cell…”
Get full text

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study by Mussetti, A., Rius-Sansalvador, B., Moreno, V., Peczynski, C., Polge, E., Galimard, J. E., Kröger, N., Blaise, D., Peffault de Latour, R., Kulagin, A., Mousavi, A., Stelljes, M., Hamladji, R. M., Middeke, J. M., Salmenniemi, U., Sengeloev, H., Forcade, E., Platzbecker, U., Reményi, P., Angelucci, E., Chevallier, P., Yakoub-Agha, I., Craddock, C., Ciceri, F., Schroeder, T., Aljurf, M., Ch, Koenecke, Moiseev, I., Penack, O., Schoemans, H., Mohty, M., Glass, B., Sureda, A., Basak, G., Peric, Z.

“…Allogeneic haematopoietic cell transplantation (alloHCT) has curative potential counterbalanced by its toxicity. Prognostic scores fail to include current era…”
Get full text

Ocular chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation in Denmark (1971–2011): Incidence and risk factors in adults by Jeppesen, H., Sengeloev, H., Eriksson, F., Kiilgaard, J.F., Lindegaard, J., Julian, H.O., Heegaard, S.

“…Purpose Ocular chronic graft‐versus‐host disease (cGVHD) is a bothersome complication to allogeneic hematopoietic stem cell transplantation (HSCT). The…”
Get full text

Ocular Chronic Graft Versus Host Disease after Bone Marrow Transplantation by Jeppesen, H., Sengeloev, H., Lindegaard, J., Julian, H., Prause, J.U., Heegaard, S.

“…Purpose Allogeneic bone marrow transplantation (BMT) is a curative therapy for a number of hematological diseases. Ocular chronic graft versus host disease…”
Get full text

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party by Koenecke, C, Heim, D, van Biezen, A, Heuser, M, Aljurf, M, Kyrcz-Krzemien, S, Volin, L, de Souza, C A, Gedde-Dahl, T, Sengeloev, H, Schanz, U, Komarnicki, M, Arroyo, C H, Tholouli, E, Gluckman, E, Esquirol, A, Yakoub-Agha, I, Gürman, G, Olavarria, E, Kröger, N

Get full text

PD-0171 Lung function after total body irradiation in myeloablative allogeneic stem cell transplantation by Wang, X., Mortensen, J., Sengeloev, H., Kjaer-Kristoffersen, F., Meidahl Petersen, P., Specht, L.

Get full text

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group by Averbuch, Diana, Tridello, Gloria, Hoek, Jennifer, Mikulska, Malgorzata, Akan, Hamdi, San Segundo, Lucrecia Yaňez, Pabst, Thomas, Özçelik, Tülay, Klyasova, Galina, Donnini, Irene, Wu, Depei, Gülbas, Zafer, Zuckerman, Tsila, de Sousa, Aida Botelho, Beguin, Yves, Xhaard, Aliénor, Bachy, Emmanuel, Ljungman, Per, de la Camara, Rafael, Rascon, Jelena, Camps, Isabel Ruiz, Vitek, Antonin, Patriarca, Francesca, Cudillo, Laura, Vrhovac, Radovan, Shaw, Peter J., Wolfs, Tom, O’Brien, Tracey, Avni, Batia, Silling, Gerda, Sabty, Firas Al, Graphakos, Stelios, Sankelo, Marja, Sengeloev, Henrik, Pillai, Srinivas, Matthes, Susanne, Melanthiou, Frederiki, Iacobelli, Simona, Styczynski, Jan, Engelhard, Dan, Cesaro, Simone

“…This intercontinental study aimed to study gram-negative rod (GNR) resistance in hematopoietic stem cell transplantation (HSCT). GNR bacteremias occurring…”
Get full text

Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties by Cseh, Annamária, Galimard, Jacques-Emmanuel, de la Fuente, Josu, Isgro, Antonella, Zecca, Marco, Garwer, Birgit, Biffi, Alexandra, Aljurf, Mahmoud, Sundin, Mikael, Belendez, Cristina, Locatelli, Franco, Balduzzi, Adriana, Lawson, Sarah, Sengeloev, Henrik, Ifversen, Marianne, Saccardi, Riccardo, Wynn, Robert, Lankester, Arjan C, Corbacioglu, Selim, Peters, Christina

“…How important is choice of conditioning regimen in allogeneic haematopoietic stem cell transplantation (HSCT) for sickle cell disease (SCD)? We compared HSCT…”
Get full text

Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT by Montoro, Juan, Eikema, Dirk-Jan, Tuffnell, Joe, Potter, Victoria, Kalwak, Krzysztof, Halkes, Constantijn J. M., Kulagin, Alexander, Collin, Matthew, Wynn, Robert F., Robinson, Stephen, Nicholson, Emma, Sengeloev, Henrik, Clay, Jennifer, Halahleh, Khalid, Skorobogatova, Elena, Sanz, Jaime, Passweg, Jakob, Mielke, Stephan, Ryhänen, Samppa, Carpenter, Ben, Gedde-Dahl, Tobias, Tholouli, Eleni, Fanin, Renato, Lewalle, Philippe, Kulasekararaj, Austin, Risitano, Antonio, Peffault de Latour, Régis

“…•SCT from MUD offers superior survival outcomes for severe aplastic anemia compared with both MMUD and Haplo SCT.•The decision between an MMUD and Haplo donor…”
Get full text

Alternative Donor Transplantation for Severe Aplastic Anemia: A Comparative Study of the Saawp EBMT by Montoro, Juan, Eikema, Dirk-Jan, Tuffnell, Joe, Potter, Victoria, Kalwak, Krzysztof, Halkes, Stijn, Kulagin, Aleksandr, Collin, Matthew P., Wynn, Robert, Robinson, Stephen, Nicholson, Emma, Sengeloev, Henrik, Clay, Jennifer, Halahleh, Khaled, Skorobogatova, Elena, Passweg, Jakob, Mielke, Stephan, Ryhanen, Samppa, Carpenter, Ben, Gedde-Dahl, Tobias, Tholouli, Eleni, Fanin, Renato, Lewalle, Philippe, Kulasekararaj, Austin, Risitano, Antonio M, Peffault De Latour, Regis

“…Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT INTRODUCTION Allogeneic stem cell transplantation…”
Get full text

Relapse Incidence Post Unrelated Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide (PTCy) Versus Conventional Anti-Graft Versus Host Disease Prophylaxis in Patients with Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation by Nagler, Arnon, Ngoya, Maud, Galimard, Jacques-Emmanuel, Labopin, Myriam, Wolfgang Blau, Igor, Kröger, Nicolaus, Gedde-Dahl, Tobias, Schroeder, Thomas, Burns, David, Salmenniemi, Urpu, Rambaldi, Alessandro, Choi, Goda, Peffault De Latour, Regis, Vydra, Jan, Sengeloev, Henrik, Eder, Matthias, Mielke, Stephan, Forcade, Edouard, Bondarenko, Sergey, Ciceri, Fabio, Mohty, Mohamad

“…Background: Recently, the BMT CTN 1703 phase III study compared post-transplant cyclophosphamide with tacrolimus with mycophenolate mofetil (PTCy/TAC/MMF) to…”
Get full text

Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT by Pagliuca, Simona, Mooyaart, Jarl, Kröger, Nicolaus, Finke, Jürgen, Potter, Victoria, Dreger, Peter, Hilgendorf, Inken, Bethge, Wolfgang Andreas, Peffault De Latour, Regis, Rambaldi, Alessandro, Sengeloev, Henrik, Passweg, Jakob, Gedde-Dahl, Tobias, Burns, David, Orchard, Kim, Mielke, Stephan, Edinger, Matthias, Andreani, Marco, Crivello, Pietro, Merli, Pietro, Hoogenboom, Jorinde D., de Wreede, Liesbeth C., Chabannon, Christian, Kuball, Jurgen, Gurnari, Carmelo, Fleischhauer, Katharina, Ruggeri, Annalisa, Lenz, Tobias

“…In allogeneic hematopoietic cell transplantation (allo-HCT), alloreactive T-cell responses (graft versus leukemia - GvL and graft versus host disease - GvHD)…”
Get full text

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT by Cahu, X, Labopin, M, Giebel, S, Aljurf, M, Kyrcz-Krzemien, S, Socié, G, Eder, M, Bonifazi, F, Bunjes, D, Vigouroux, S, Michallet, M, Stelljes, M, Zuckerman, T, Finke, J, Passweg, J, Yakoub-Agha, I, Niederwieser, D, Sucak, G, Sengeløv, H, Polge, E, Nagler, A, Esteve, J, Mohty, M

“…Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a therapeutic option for adult patients with T-cell ALL (T-ALL). Meanwhile, few allo-SCT data…”
Get full text

Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT by Henoun Loukili, Noureddine, Gras, Luuk, Koster, Linda, Blaise, Didier, Gedde-Dahl, Tobias, Maertens, Johan, Peffault De Latour, Regis, Sengeloev, Henrik, Mielke, Stephan, Chevallier, Patrice, Passweg, Jakob R., Byrne, Jenny Louise, Salmenniemi, Urpu, Sirvent, Anne, Guyotat, Denis, Sica, Simona, de Wreede, Liesbeth C., Onida, Francesco, Scheid, Christoph, Gurnari, Carmelo, Drozd-Sokolowska, Joanna, Raj, Kavita, Robin, Marie, McLornan, Donal P, Yakoub-Agha, Ibrahim

“…Introduction Myelodysplastic syndromes (MDS) affect mainly older individuals, with a median age > 70 years. Reduced intensity conditioning (RIC) is usually…”
Get full text

Graft-Versus-Host Disease after Anti-CD19 Chimeric Antigen Receptor T-Cell Infusion Post Allogeneic Hematopoietic Cell Transplantation: A Transplant Complications and Paediatric Disease Working Parties EBMT Joint Study by Orti, Guillermo, Peczynski, Christophe, Koenecke, Christian, Boreland, William, O'Reilly, Maeve, Bornhäuser, Martin, Balduzzi, Adriana, Besley, Caroline, Kalwak, Krzysztof, Ryhanen, Samppa, Güngör, Tayfun, Wynn, Robert F., Bader, Peter, Mielke, Stephan, Blaise, Didier, Amrolia, Persis, Yakoub-Agha, Ibrahim, Calkoen, Friso G. J., Schubert, Maria-Luisa, Potter, Victoria, Holter, Wolfgang, Kröger, Nicolaus, Kwon, Mi, Sengeloev, Henrik, Schoemans, Helene, Moiseev, Ivan Sergeevich, Penack, Olaf, Peric, Zinaida

“…Background Anti-CD19 chimeric antigen receptor T-cells (CART) have been incorporated into the therapeutic landscape of B-acute lymphoblastic leukemia (B-ALL)…”
Get full text

Allogeneic hematopoietic cell transplantation in patients with CML chronic phase in the era of third generation tyrosine kinase inhibitors: a retrospective study by the Chronic Malignancies Working Party of the EBMT by Chalandon, Y., Sbianchi, G., Gras, L., Koster, L., Apperley, J., Byrne, J., Salmenniemi, U., Sengeloev, H., Aljurf, M., Helbig, G., Kinsella, F., Choi, G., Reményi, P., Snowden, J. A., Robin, Marie, Lenhoff, S., Mielke, S., Passweg, J., Broers, A. E. C., Kröger, N., Yegin, Z. A., Tan, S. M., Hayden, P. J., Mclornan, D. P., Yakoub-Agha, Ibrahim

“…Following the introduction of tyrosine kinase inhibitors (TKI), the number of patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) for…”
Get full text

Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT by Chalandon, Yves, Sbianchi, Giulia, Gras, Luuk, Koster, Linda, Apperley, Jane, Byrne, Jenny, Salmenniemi, Urpu, Sengeloev, Henrik, Aljurf, Mahmoud, Helbig, Grzegorz, Kinsella, Francesca, Choi, Goda, Reményi, Péter, Snowden, John A., Robin, Marie, Lenhoff, Stig, Mielke, Stephan, Passweg, Jakob, Broers, Annoek E. C., Kröger, Nicolaus, Yegin, Zeynep Arzu, Tan, Sen Mui, Hayden, Patrick J., McLornan, Donal P., Yakoub‐Agha, Ibrahim

“…Following the introduction of tyrosine kinase inhibitors (TKI), the number of patients undergoing allogeneic hematopoietic cell transplantation (allo‐HCT) for…”
Get full text

Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT by Giebel, Sebastian, Labopin, Myriam, Potter, Michael, Poiré, Xavier, Sengeloev, Henrik, Socié, Gerard, Huynh, Anne, Afanasyev, Boris V., Schanz, Urs, Ringden, Olle, Kalhs, Peter, Beelen, Dietrich W., Campos, Antonio M., Masszi, Tamás, Canaani, Jonathan, Mohty, Mohamad, Nagler, Arnon

“…Allogeneic haematopoietic stem cell transplantation (alloHSCT) is considered a standard treatment for patients with Philadelphia chromosome–positive acute…”
Get full text

Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT by Forcade, Edouard, Chevret, Sylvie, Finke, Jürgen, Ehninger, Gerhard, Ayuk, Francis, Beelen, Dietrich, Koster, Linda, Ganser, Arnold, Volin, Liisa, Sengeloev, Henrik, Michallet, Mauricette, Tischer, Johanna, Jindra, Pavel, Cascon, Maria Jesús Pascual, Koc, Yener, Arat, Mutlu, Tomaszewska, Agnieszka, Hayden, Patrick, de Witte, Theo, Yakoub-Agha, Ibrahim, Kröger, Nicolaus, Robin, Marie

“…While in vivo T-cell depletion (TCD) is widely used, its benefit in patients with MDS still remains a matter of debate. This study evaluates the impact of TCD…”
Get full text

Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation by Nagler, Arnon, Ngoya, Maud, Galimard, Jacques‐Emmanuel, Labopin, Myriam, Blau, Igor Wolfgang, Kröger, Nicolaus, Gedde‐Dahl, Tobias, Schroeder, Thomas, Burns, David, Salmenniemi, Urpu, Rambaldi, Alessandro, Choi, Goda, Peffault de Latour, Régis, Vydra, Jan, Sengeloev, Henrik, Eder, Matthias, Mielke, Stephan, Forcade, Edouard, Kulagin, Alexander, Ciceri, Fabio, Mohty, Mohamad

“…We compared relapse incidence (RI) post‐unrelated transplantation with post‐transplant cyclophosphamide (PTCy) versus no PTCy graft‐versus‐host disease (GVHD)…”
Get full text